Accumulated evidence showed that overactivated PI3K/Akt/mTOR signaling pathway frequently occurs in HCC, which was highly correlated with poor prognosis and poor overall survival [45, 46]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.